Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bodil Petersen

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|November 20, 2008
[Inhaled nitric oxide for rescue treatment of refractory hypoxemia in ARDS patients]Thilo Busch, Sven Bercker, Sven Laudi, et al.
Laboratory Animals|November 27, 2016
Search for an animal model to investigate selective pulmonary vasodilationBodil Petersen, Thilo Busch, Katharina Noreikat, et al.
Nature Protocols|March 8, 2008
A protocol for a lung neovascularization model in rodentsRosemary C Jones, Diane Capen, Bodil Petersen, et al.
Clinical Science (London, England : 1979)|August 24, 2002
The inhaled ET(A) receptor antagonist LU-135252 acts as a selective pulmonary vasodilatorMaria Deja, Steffen Wolf, Thilo Busch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2006
Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosisBodil Petersen, Klaus Bendtzen, Nils Koch-Henriksen, et al.
Journal of Cardiovascular Pharmacology|April 20, 2005
Inhalation of the endothelin-A receptor antagonist LU-135252 at various doses in experimental acute lung injuryMaria Deja, Thilo Busch, Steffen Wolf, et al.
Anesthesiology|September 22, 2011
Cysteinyl leukotrienes impair hypoxic pulmonary vasoconstriction in endotoxemic miceBodil Petersen, K Frank Austen, Kenneth D Bloch, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 3, 2006
Endothelin-1 influences the efficacy of inhaled nitric oxide in experimental acute lung injuryThilo Busch, Bodil Petersen, Maria Deja, et al.
Canadian Journal of Physiology and Pharmacology|September 2, 2008
Inhalation of an endothelin receptor A antagonist attenuates pulmonary inflammation in experimental acute lung injuryPhilipp Kalk, Philine Senf, Maria Deja, et al.
Respiratory Research|June 5, 2019
Arginase impairs hypoxic pulmonary vasoconstriction in murine endotoxemiaBodil Petersen, Cornelius J Busch, Grigorij Schleifer, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|November 20, 2008
[Inhaled nitric oxide for rescue treatment of refractory hypoxemia in ARDS patients]Thilo Busch, Sven Bercker, Sven Laudi, et al.
Laboratory Animals|November 27, 2016
Search for an animal model to investigate selective pulmonary vasodilationBodil Petersen, Thilo Busch, Katharina Noreikat, et al.
Nature Protocols|March 8, 2008
A protocol for a lung neovascularization model in rodentsRosemary C Jones, Diane Capen, Bodil Petersen, et al.
Clinical Science (London, England : 1979)|August 24, 2002
The inhaled ET(A) receptor antagonist LU-135252 acts as a selective pulmonary vasodilatorMaria Deja, Steffen Wolf, Thilo Busch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2006
Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosisBodil Petersen, Klaus Bendtzen, Nils Koch-Henriksen, et al.
Journal of Cardiovascular Pharmacology|April 20, 2005
Inhalation of the endothelin-A receptor antagonist LU-135252 at various doses in experimental acute lung injuryMaria Deja, Thilo Busch, Steffen Wolf, et al.
Anesthesiology|September 22, 2011
Cysteinyl leukotrienes impair hypoxic pulmonary vasoconstriction in endotoxemic miceBodil Petersen, K Frank Austen, Kenneth D Bloch, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 3, 2006
Endothelin-1 influences the efficacy of inhaled nitric oxide in experimental acute lung injuryThilo Busch, Bodil Petersen, Maria Deja, et al.
Canadian Journal of Physiology and Pharmacology|September 2, 2008
Inhalation of an endothelin receptor A antagonist attenuates pulmonary inflammation in experimental acute lung injuryPhilipp Kalk, Philine Senf, Maria Deja, et al.
Respiratory Research|June 5, 2019
Arginase impairs hypoxic pulmonary vasoconstriction in murine endotoxemiaBodil Petersen, Cornelius J Busch, Grigorij Schleifer, et al.
Pageof 2